- Home
- HHS vs HBIO Comparison
HHS vs HBIO Comparison
Compare HHS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- HBIO
- Stock Information
- Founded
- HHS 1923
- HBIO 1901
- Country
- HHS United States
- HBIO United States
- Employees
- HHS N/A
- HBIO N/A
- Industry
- HHS Advertising
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- HHS Consumer Discretionary
- HBIO Industrials
- Exchange
- HHS Nasdaq
- HBIO Nasdaq
- Market Cap
- HHS 27.3M
- HBIO 24.6M
- IPO Year
- HHS N/A
- HBIO 2000
- Fundamental
- Price
- HHS $3.64
- HBIO $0.49
- Analyst Decision
- HHS
- HBIO Buy
- Analyst Count
- HHS 0
- HBIO 2
- Target Price
- HHS N/A
- HBIO $3.00
- AVG Volume (30 Days)
- HHS 9.2K
- HBIO 505.4K
- Earning Date
- HHS 08-07-2025
- HBIO 08-11-2025
- Dividend Yield
- HHS N/A
- HBIO N/A
- EPS Growth
- HHS N/A
- HBIO N/A
- EPS
- HHS N/A
- HBIO N/A
- Revenue
- HHS $174,951,000.00
- HBIO $88,750,000.00
- Revenue This Year
- HHS $6.54
- HBIO N/A
- Revenue Next Year
- HHS N/A
- HBIO $7.13
- P/E Ratio
- HHS N/A
- HBIO N/A
- Revenue Growth
- HHS N/A
- HBIO N/A
- 52 Week Low
- HHS $3.06
- HBIO $0.28
- 52 Week High
- HHS $7.72
- HBIO $3.04
- Technical
- Relative Strength Index (RSI)
- HHS 52.21
- HBIO 48.68
- Support Level
- HHS $3.59
- HBIO $0.49
- Resistance Level
- HHS $3.72
- HBIO $0.54
- Average True Range (ATR)
- HHS 0.13
- HBIO 0.04
- MACD
- HHS 0.01
- HBIO -0.00
- Stochastic Oscillator
- HHS 37.14
- HBIO 19.20
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.